Xiaoan Wen,Hongbin Sun,Jun Liu,Keguang Cheng,Pu Zhang,Liying Zhang,Jia Hao,Luyong Zhang,Peizhou Ni,Spyros E. Zographos,Demetres D. Leonidas,Kyra-Melinda Alexacou,Thanasis Gimisis,Joseph M. Hayes,Nikos G. Oikonomakos

Abstract:Twenty-five naturally occurring pentacyclic triterpenes, 15 of which were synthesized in this study, were biologically evaluated as inhibitors of rabbit muscle glycogen phosphorylase a (GPa). From SAR studies, the presence of a sugar moiety in triterpene saponins resulted in a markedly decreased activity (7, 18-20) or no activity (21, 22). These saponins, however, might find their value as potential natural prodrugs which are much more water-soluble than their corresponding aglycones. To elucidate the mechanism of GP inhibition, we have determined the crystal structures of the GPb-asiatic acid and GPb-maslinic acid complexes. The X-ray analysis indicates that the inhibitors bind at the allosteric activator site, where the physiological activator AMP binds. Pentacyclic triterpenes represent a promising class of multiple-target antidiabetic agents that exert hypoglycemic effects, at least in part, through GP inhibition.

Terpenoids. III: Synthesis and biological evaluation of 23-hydroxybetulinic acid derivatives as novel inhibitors of glycogen phosphorylase.

Terpenoids. Part 3. Synthesis and Biological Evaluation of 23‐Hydroxybetulinic Acid Derivatives as Novel Inhibitors of Glycogen Phosphorylase.

Pentacyclic triterpenes. Part 3: Synthesis and biological evaluation of oleanolic acid derivatives as novel inhibitors of glycogen phosphorylase

Design, Synthesis and Biological Evaluation of Novel Pyrimidinedione Derivatives As DPP-4 Inhibitors.

Pentacyclic triterpenes. Part 2: Synthesis and biological evaluation of maslinic acid derivatives as glycogen phosphorylase inhibitors.

Synthesis and biological evaluation of novel pyrazolo[4,3-b]oleanane derivatives as inhibitors of glycogen phosphorylase.

Identification of Pentacyclic Triterpenes Derivatives As Potent Inhibitors Against Glycogen Phosphorylase Based on 3D-QSAR Studies

Synthesis and Biological Evaluation of Ambradiolic Acid As an Inhibitor of Glycogen Phosphorylase

Design, Synthesis and Biological Evaluation of Novel (Quinolinyl-3-pyridinyl)benzenesulfonamide-based Hydroxamic Acids As PI3K and HDAC Dual Targeting Inhibitors

Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structure-activity relationships, and X-ray crystallographic studies.

Synthesis Of 3-Deoxypentacyclic Triterpene Derivatives As Inhibitors Of Glycogen Phosphorylase

Design, Synthesis, and Evaluation of 3‐aryl‐4‐pyrrolyl‐maleimides As Glycogen Synthase Kinase‐3β Inhibitors

Synthesis and Biological Evaluation of Substituted Phenylpyrazole[4,5-B]oleanane Derivatives As Inhibitors of Glycogen Phosphorylase.

Synthesis and Evaluation of 3-Anilino-quinoxalinones As Glycogen Phosphorylase Inhibitors.

Discovering benzamide derivatives as glycogen phosphorylase inhibitors and their binding site at the enzyme.

Synthesis and Biological Activity of Heterocycle-Fused Derivatives of Pentacylic Triterpenes As Glycogen Phosphorylase Inhibitors

Synthesis and biological evaluation of asiatic acid derivatives as inhibitors of glycogen phosphorylases.

Synthesis and Biological Evaluation of Arjunolic Acid, Bayogenin, Hederagonic Acid and 4-Epi-hederagonic Acid as Glycogen Phosphorylase Inhibitors

Synthesis and Biological Evaluation of Ursolic Acid Derivatives As Novel Inhibitors of Glycogen Phosphorylase

Design, Synthesis and Evaluation of Pentacyclic Triterpenoids Similar to Glycyrrhetinic Acid Via Combination of Chemical and Microbial Modification As Glycogen Phosphorylases Inhibitor

Pentacyclic triterpenes. Part 1: the first examples of naturally occurring pentacyclic triterpenes as a new class of inhibitors of glycogen phosphorylases